NCT02602314 2022-01-20
SUSTRENIM
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 4 Unknown
Clinical Trials
4 trialsNCT03332511 2017-11-06
ENESTKorea
Seoul National University Hospital
Phase 4 Completed
NCT02086487 2017-03-07
NISRI
King Abdullah International Medical Research Center
Phase 4 Terminated
NCT02389920 2015-03-17
Multicenter, Phaseâ…£, Open Label Trial of Nilotinib in Adult Patients Diagnosed Philadelphia Chromosome Positive(Ph+) Chronic Myeloid Leukemia in CP/AP Intolerant to Dasatinib
Samsung Medical Center
Phase 4 Unknown